We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-9 of 9 results

  1. Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

    Introduction

    Clinical practice studies help guide antiepileptic drug (AED) therapy in patient groups routinely excluded from clinical trials, such as...

    Charlotte Lawthom, Pedro Bermejo, ... Vicente Villanueva in Neurology and Therapy
    Article Open access 16 May 2019

  2. Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience

    Introduction

    The prevalence of epilepsy increases in elderly patients aged > 65 years, and treatment is challenging because clinical data are limited.

    ...
    Luís M. Magalhães, Raquel Costa, ... Patrício Soares-da-Silva in Drug Safety
    Article Open access 18 September 2021

  3. Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures

    The Euro-Esli study was an exploratory pooled analysis of data from 14 European clinical practice studies, which was conducted to audit the...

    Vicente Villanueva, Martin Holtkamp, ... Patricia Santagueda in Journal of Neurology
    Article Open access 18 September 2017

  4. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures

    Eslicarbazepine acetate (Zebinix ® ), a voltage-gated sodium channel blocker, is a once-daily, orally administered anti-seizure medication available in...

    Young-A Heo in CNS Drugs
    Article 31 July 2020

  5. Effektivität von Eslicarbazepinacetat in 2 unterschiedlichen Kohorten von Patienten mit Epilepsie in der klinischen Praxis – Ergebnisse einer retrospektiven Datensammlung aus 2 Epilepsiezentren in Deutschland

    Background

    Eslicarbazepine acetate (ESL) is a third generation antiepileptic drug (AED) licensed in the EU as adjunctive therapy for partial-onset...

    C. Brandt, M. Holtkamp, ... E. Kockelmann in Zeitschrift für Epileptologie
    Article Open access 12 March 2019

  6. Mitteilungen der DGN

    in Der Nervenarzt
    Article 10 August 2017

  9. Das ELSI-Programm des U.S.-amerikanischen Humangenomprojekts – neue Perspektiven für die Medizinethik?

    Definition of the problem: The ELSI (Ethical, Legal, and Social Issues) program of the Human Genome Project is the biggest bioethical research...

    Nikola Biller-Andorno in Ethik in der Medizin
    Article 01 December 2001
Did you find what you were looking for? Share feedback.